These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 11709783)

  • 1. Cervicovaginal secretory antibodies to human immunodeficiency virus type 1 (HIV-1) that block viral transcytosis through tight epithelial barriers in highly exposed HIV-1-seronegative African women.
    Bélec L; Ghys PD; Hocini H; Nkengasong JN; Tranchot-Diallo J; Diallo MO; Ettiègne-Traore V; Maurice C; Becquart P; Matta M; Si-Mohamed A; Chomont N; Coulibaly IM; Wiktor SZ; Kazatchkine MD
    J Infect Dis; 2001 Dec; 184(11):1412-22. PubMed ID: 11709783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Limited secretory-IgA response in cervicovaginal secretions from HIV-1 infected, but not high risk seronegative women: lack of correlation to genital viral shedding.
    Fiore JR; Laddago V; Lepera A; La Grasta L; Di Stefano M; Saracino A; Lopalco P; Pastore G; Angarano G
    New Microbiol; 2000 Jan; 23(1):85-92. PubMed ID: 10946410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-gp160 IgG and IgA antibodies associated with a large increase in total IgG in cervicovaginal secretions from human immunodeficiency virus type 1-infected women.
    Lu XS; Bélec L; Pillot J
    J Infect Dis; 1993 May; 167(5):1189-92. PubMed ID: 8486953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 gp41-specific monoclonal mucosal IgAs derived from highly exposed but IgG-seronegative individuals block HIV-1 epithelial transcytosis and neutralize CD4(+) cell infection: an IgA gene and functional analysis.
    Tudor D; Derrien M; Diomede L; Drillet AS; Houimel M; Moog C; Reynes JM; Lopalco L; Bomsel M
    Mucosal Immunol; 2009 Sep; 2(5):412-26. PubMed ID: 19587640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cervicovaginal anti-HIV antibodies in HIV-seronegative female sex workers in Abidjan, Côte d'Ivoire.
    Ghys PD; Bélec L; Diallo MO; Ettiègne-Traoré V; Becquart P; Maurice C; Nkengasong JN; Coulibaly IM; Greenberg AE; Laga M; Wiktor SZ
    AIDS; 2000 Nov; 14(16):2603-8. PubMed ID: 11101074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiologic and biologic characterization of a cohort of human immunodeficiency virus type 1 highly exposed, persistently seronegative female sex workers in northern Thailand. Chiang Mai HEPS Working Group.
    Beyrer C; Artenstein AW; Rugpao S; Stephens H; VanCott TC; Robb ML; Rinkaew M; Birx DL; Khamboonruang C; Zimmerman PA; Nelson KE; Natpratan C
    J Infect Dis; 1999 Jan; 179(1):59-67. PubMed ID: 9841823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of cervicovaginal humoral immunity in clinically asymptomatic (CDC A1 and A2 category) patients with HIV-1 and HIV-2 infection.
    Bélec L; Tévi-Bénissan C; Dupré T; Mohamed AS; Prazuck T; Gilquin J; Kanga JM; Pillot J
    J Clin Immunol; 1996 Jan; 16(1):12-20. PubMed ID: 8926281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cervicovaginal HIV-1-neutralizing immunoglobulin A detected among HIV-1-exposed seronegative female partners in HIV-1-discordant couples.
    Choi RY; Levinson P; Guthrie BL; Lohman-Payne B; Bosire R; Liu AY; Hirbod T; Kiarie J; Overbaugh J; John-Stewart G; Broliden K; Farquhar C
    AIDS; 2012 Nov; 26(17):2155-63. PubMed ID: 22948273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cervicovaginal anti-HIV antibodies in index women from HIV-discordant, exclusively heterosexual, couples.
    Bélec L; Prazuck T; Payan C; Mohamed AS; Cancre N; Hocini H; Malkin JE; Pillot J
    Viral Immunol; 1996; 9(3):155-8. PubMed ID: 8890473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repetitive and consistent cervicovaginal exposure to certain viral pathogens appears to protect against their sexual acquisition in some women: potential mechanisms.
    Laurence J
    J Reprod Immunol; 2003 Feb; 58(1):79-91. PubMed ID: 12609527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cervicovaginal synthesis of IgG antibodies to the immunodominant 175-199 domain of the surface glycoprotein gp46 of human T-cell leukemia virus type I.
    Bélec L; Georges-Courbot MC; Georges A; Mohamed AS; Londos-Gagliardi D; Hallouin MC; Hocini H; Guillemain B
    J Med Virol; 1996 Sep; 50(1):42-9. PubMed ID: 8890040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local synthesis of IgG antibodies to HIV within the female and male genital tracts during asymptomatic and pre-AIDS stages of HIV infection.
    Bélec L; Tévi-Bénissan C; Lu XS; Prazuck T; Pillot J
    AIDS Res Hum Retroviruses; 1995 Jun; 11(6):719-29. PubMed ID: 7576932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 specific IgA detected in vaginal secretions of HIV uninfected women participating in a microbicide trial in Southern Africa are primarily directed toward gp120 and gp140 specificities.
    Seaton KE; Ballweber L; Lan A; Donathan M; Hughes S; Vojtech L; Moody MA; Liao HX; Haynes BF; Galloway CG; Richardson BA; Karim SA; Dezzutti CS; McElrath MJ; Tomaras GD; Hladik F
    PLoS One; 2014; 9(7):e101863. PubMed ID: 25054205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucosal and plasma IgA from HIV-exposed seronegative individuals neutralize a primary HIV-1 isolate.
    Devito C; Hinkula J; Kaul R; Lopalco L; Bwayo JJ; Plummer F; Clerici M; Broliden K
    AIDS; 2000 Sep; 14(13):1917-20. PubMed ID: 10997395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secretory IgA specific for a conserved epitope on gp41 envelope glycoprotein inhibits epithelial transcytosis of HIV-1.
    Alfsen A; Iniguez P; Bouguyon E; Bomsel M
    J Immunol; 2001 May; 166(10):6257-65. PubMed ID: 11342649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of pregnancy on anti-HIV activity of cervicovaginal secretions.
    Hughes BL; Dutt R; Raker C; Barthelemy M; Rossoll RM; Ramratnam B; Wira CR; Cu-Uvin S
    Am J Obstet Gynecol; 2016 Dec; 215(6):748.e1-748.e12. PubMed ID: 27393267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-level ability of secretory IgA to block HIV type 1 transcytosis: contrasting secretory IgA and IgG responses to glycoprotein 160.
    Hocini H; Bélec L; Iscaki S; Garin B; Pillot J; Becquart P; Bomsel M
    AIDS Res Hum Retroviruses; 1997 Sep; 13(14):1179-85. PubMed ID: 9310284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cervicovaginal levels of lactoferrin, secretory leukocyte protease inhibitor, and RANTES and the effects of coexisting vaginoses in human immunodeficiency virus (HIV)-seronegative women with a high risk of heterosexual acquisition of HIV infection.
    Novak RM; Donoval BA; Graham PJ; Boksa LA; Spear G; Hershow RC; Chen HY; Landay A
    Clin Vaccine Immunol; 2007 Sep; 14(9):1102-7. PubMed ID: 17671228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of a high sensitive immunoenzymatic assay to establish the origin of immunoglobulins in female genital secretions.
    Bard E; Riethmuller D; Biichlé S; Meillet D; Prétet JL; Mougin C; Seillès E
    J Immunoassay Immunochem; 2002; 23(2):145-62. PubMed ID: 12033640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cervicovaginal overproduction of specific IgG to human immunodeficiency virus (HIV) contrasts with normal or impaired IgA local response in HIV infection.
    Bélec L; Dupré T; Prazuck T; Tévi-Bénissan C; Kanga JM; Pathey O; Lu XS; Pillot J
    J Infect Dis; 1995 Sep; 172(3):691-7. PubMed ID: 7658060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.